In the News
Dermatology Times VYN201 Interview: Iain Stuart
May 22nd, 2024
Vyne Therapeutics’ CEO explains the rationale for using BET inhibition for autoimmune diseases
June 25th, 2024
Dermatology Times VYN202 Interview: Iain Stuart
July 3rd, 2024
*For Educational Purposes Only. All products mentioned are investigational new drugs and have not been shown to be safe or effective for FDA purposes. The investigational products are not available for commercial use.